Proteases II pp 123-131 | Cite as

Functional Studies of Human Secretory Leukocyte Protease Inhibitor

  • Kjell Ohlsson
  • Magnus Bergenfeldt
  • Peter Björk
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 240)


The balance between the concentrations of proteases and their inhibitors is of vital importance to the physiology of a number of tissues including the lung. The proteases in the lung mainly come from infiltrating neutrophils and macrophages and when released from these cells can cause extensive tissue degradation unless they are inactivated by protease inhibitors. One of the major protease inhibitors found in the lung tissue is alpha-l-protease inhibitor (alpha-l-PI) which blocks the activity of neutrophil elastase (1) and cathepsin G (2).


Seminal Plasma Secretory Leukocyte Protease Inhibitor Elastase Inhibitor Leukocyte Elastase Human Mucous Secretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ohlsson, K. Neutral leukocyte proteases and elastase inhibited by plasma α1-antitrypsin. Scand. J. Clin. Lab. Invest. (1971) 28: 251–253.PubMedCrossRefGoogle Scholar
  2. 2.
    Venge, P., Olsson, I., Odeberg, H. Cationic proteins of human granulocytes. V. Interaction with plasma protease inhibitors. Scand. J. Clin. Lab. Invest. (1978) 35: 737–744.CrossRefGoogle Scholar
  3. 3.
    Schiessler, H., Hochstrasser, K., Ohlsson, K. in Neutral Proteases and Human Polymorphonuclear Leukocytes, eds. Havemann, K & Janoff, A. (Urban & Schwarzenberg, Baltimore), (1978) pp. 195–207.Google Scholar
  4. 4.
    Thompson, R.C., Ohlsson, K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. (1986), vol 83, pp. 6692–6696.PubMedCrossRefGoogle Scholar
  5. 5.
    Ohlsson, K., Tegner, H., Åkesson, U. Isolation and partial characterization of a low molecular weight acid stable protease inhibitor from human bronchial secretion. Hoppe-Seyler’s Z. Physiol. Chem. (1977) 358: 583–589.PubMedCrossRefGoogle Scholar
  6. 6.
    Klassen, E.C., Kramps, J.A. The N-terminal sequence of antileukoprotease isolated from bronchial secretion. Biochem.Biophys.Res.Commun. (1985) 128: 285–289.CrossRefGoogle Scholar
  7. 7.
    Seemüller, U., Arnhold, M., Fritz, H., Wiedenmann, K., Machleidt, W., Heinzel, R., Appelhans, H., Gassen, H.-G., Lottspeich, F. The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease). FEBS. (1986) Vol. 199, No.1; 43–48.CrossRefGoogle Scholar
  8. 8.
    Ohlsson, M., Fryksmark, U., Polling, Å., Tegner, H., Ohlsson, K. Localization of antileukoprotease in the parotid and submandibular salivary glands. Acta Otolaryngol (Stockh) (1984) 98: 147–151.CrossRefGoogle Scholar
  9. 9.
    Ohlsson, M., Rosengren, M., Tegner, H., Ohlsson, K. Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion. Hoppe-Seyler’s Z. Physiol. Chem (1983) 364: 1323–1328.PubMedCrossRefGoogle Scholar
  10. 10.
    Stetler, G., Brewer, M.T., Thompson, R.C. Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases. Nucleic Acids Research. (1986) vol 14, No. 20; 7883–7896.PubMedCrossRefGoogle Scholar
  11. 11.
    Smith, C.E., Johnson, P.A. Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases. Biochem. J. (1985) 225, 463–472.PubMedGoogle Scholar
  12. 12.
    Fryksmark, U., Prellner, T., Tegner, H., Ohlsson, K. Studies on the role of antileukoprotease in respiratory tract diseases. Eur J Respir Dis, (1984) 65, 201–20).PubMedGoogle Scholar
  13. 13.
    Egbring, R., Schmidt, W., Fuchs, G., Havemann, K. Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects. Blood, (1977) 49: 219–231.PubMedGoogle Scholar
  14. 14.
    Aasen, A.O., Ohlsson, K. Release of granulocyte elastase in lethal canine endotoxin shock. Hoppe Seyler’s Z. Physiol. Chem. (1978) 359: 683–690.PubMedGoogle Scholar
  15. 15.
    Jochum, M., Witte, J., Schiessler, H., Selbmann, H.K., Ruckdeschl, G., Fritz, H. Clotting and other plasma factors in experimental endotoxemia: Inhibition of degradation by exogenous proteinase inhibitors. Eur. Surg. Res. (1981) 13: 152–168.PubMedCrossRefGoogle Scholar
  16. 16.
    Ohlsson, K. Collagenase and elastase released during peritonitis are complexed by plasma protease inhibitors. Surgery, (1976) Vol. 79, No. 6: 652–657.PubMedGoogle Scholar
  17. 17.
    Bruch, M., Bieth, J.G. Influence of elastin on the inhibition of leucocyte elastase by α1-proteinase inhibitor and bronchial inhibitor. Biochem. J. (1986) 238: 269–273.PubMedGoogle Scholar
  18. 18.
    Ohlsson, K., Tegner, H. Granulocyte collagenase, elastase and plasma protease inhibitors in purulent sputum. Europ. J. Clin. Invest. (1975) 5: 221–227.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Kjell Ohlsson
    • 1
  • Magnus Bergenfeldt
    • 1
  • Peter Björk
    • 1
  1. 1.Department of Surgical PathophysiologyUniversity of Lund, Malmö General HospitalMalmöSweden

Personalised recommendations